ID: ALA2030482

Max Phase: Preclinical

Molecular Formula: C12H13ClN2O2

Molecular Weight: 252.70

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COCCNC(=O)c1c[nH]c2ccc(Cl)cc12

Standard InChI:  InChI=1S/C12H13ClN2O2/c1-17-5-4-14-12(16)10-7-15-11-3-2-8(13)6-9(10)11/h2-3,6-7,15H,4-5H2,1H3,(H,14,16)

Standard InChI Key:  XXQMABUENPWBEF-UHFFFAOYSA-N

Associated Targets(Human)

Liver glycogen phosphorylase 1040 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 252.70Molecular Weight (Monoisotopic): 252.0666AlogP: 2.20#Rotatable Bonds: 4
Polar Surface Area: 54.12Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.05CX Basic pKa: CX LogP: 1.70CX LogD: 1.70
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.82Np Likeness Score: -1.52

References

1. Krimm I, Lancelin JM, Praly JP..  (2012)  Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.,  55  (3): [PMID:22229710] [10.1021/jm201439b]

Source